Literature DB >> 24134861

Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis.

Andrea Rosanoff1, Michael R Plesset.   

Abstract

Previously, we examined 44 human studies involving oral magnesium (Mg) supplementation for hypertension (HT), sorting them according to HT status, Mg dose and anti-hypertensive medication usage. We found that while some studies reported a significant lowering of blood pressure with Mg supplementation, others did not. We present here our first meta-analysis of a uniform subset from this series of studies. Seven studies, involving 135 hypertensive subjects on anti-hypertensive medication continuously for at least six months, with no more than a two-week washout and with a mean starting systolic blood pressure (SBP)>155 mmHg, demonstrated a mean change of -18.7 mmHg [95% CI=-14.95 to -22.45] p<0.0001 and an effect size test (Cohen's d)=1.19, i.e. a large and highly significant effect. Meta-analysis of diastolic blood pressure (DBP) for these same seven studies showed a mean change in DBP of -10.9 mmHg [95% CI=-8.73 to -13.1], p<0.0001, with an effect size test (Cohen's d)=1.19. Other studies from our original collection, approaching, but not meeting the >155 mmHg starting SBP values or not complying as regards anti-hypertensive medication usage, showed mean changes in both SBP and DBP with oral Mg that, while not approaching the high-responder values of the present study, appeared to include some high-responder subjects combined with low- or non-responder subjects. This uniform subset of seven studies showed a strong effect of Mg treatment in hypertension, which is in stark contrast to results of three other meta-analyses. Using non-uniform sets of studies, the small effects reported in previous meta-analyses may reflect a blending of dissimilar studies, which acted to seriously underestimate the potential of Mg in hypertension in some (but not all) subjects. Within studies, blending of non-, moderate and highresponder subjects in any one study might mask strong effects of Mg treatment in some subjects.

Entities:  

Keywords:  hypertension; meta-analysis; oral magnesium treatment

Mesh:

Substances:

Year:  2013        PMID: 24134861     DOI: 10.1684/mrh.2013.0343

Source DB:  PubMed          Journal:  Magnes Res        ISSN: 0953-1424            Impact factor:   1.115


  13 in total

1.  Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

Authors:  Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

2.  The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials.

Authors:  Daniel T Dibaba; Pengcheng Xun; Yiqing Song; Andrea Rosanoff; Michael Shechter; Ka He
Journal:  Am J Clin Nutr       Date:  2017-07-19       Impact factor: 7.045

3.  Evaluation of serum magnesium differences in hypertensive crises and control patients: A randomly matched case-control study.

Authors:  IfeanyiChukwu O Onor; Emily K Johnston; Nicole G Little; Lashira M Hill; Oluwabunmi E Lawal; Casey J Payne; Mallory R Coleman; Carolkim H Huynh; Sarah E Bilbe; Ahlam A Ayyad; Kabrea J Jones; Jasmine D Kinnard; Rosanna Dastoori; Devinn K Rolland; Amanda S Miller; Robbie A Beyl; Christopher J Gillard; John I Okogbaa; Daniel F Sarpong; Rim M Hadgu; Amne Borghol; Samuel C Okpechi; Mihran V Naljayan; Shane E Sanne; Shane G Guillory
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-08       Impact factor: 3.738

4.  Decreased magnesium status may mediate the increased cardiovascular risk associated with calcium supplementation.

Authors:  James J DiNicolantonio; Mark F McCarty; James H O'Keefe
Journal:  Open Heart       Date:  2017-05-22

Review 5.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

Review 6.  Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Hedong Han; Xin Fang; Xin Wei; Yuzhou Liu; Zhicao Jin; Qi Chen; Zhongjie Fan; Jan Aaseth; Ayako Hiyoshi; Jia He; Yang Cao
Journal:  Nutr J       Date:  2017-05-05       Impact factor: 3.271

Review 7.  Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies.

Authors:  Jiang Wu; Pengcheng Xun; Qingya Tang; Wei Cai; Ka He
Journal:  Nutr J       Date:  2017-09-19       Impact factor: 3.271

8.  Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials.

Authors:  Andrea Rosanoff; Rebecca B Costello; Guy H Johnson
Journal:  Nutrients       Date:  2021-01-10       Impact factor: 5.717

Review 9.  Magnesium in Prevention and Therapy.

Authors:  Uwe Gröber; Joachim Schmidt; Klaus Kisters
Journal:  Nutrients       Date:  2015-09-23       Impact factor: 5.717

10.  Magnesium for the prevention and treatment of cardiovascular disease.

Authors:  James J DiNicolantonio; Jing Liu; James H O'Keefe
Journal:  Open Heart       Date:  2018-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.